Zobrazeno 1 - 10
of 156
pro vyhledávání: '"Balázs Győrffy"'
Autor:
Csilla Olah, Henning Reis, Michèle J. Hoffmann, Fabian Mairinger, Saskia Ting, Boris Hadaschik, Ulrich Krafft, Viktor Grünwald, Peter Nyirady, Melinda Varadi, Balázs Győrffy, Andras Kiss, Eszter Szekely, Gottfrid Sjödahl, Tibor Szarvas
Publikováno v:
Cancer Medicine. 12:5222-5232
Objective: Although targeted approaches have become available in second- and third-line settings, platinum-based chemotherapy remains the standard first-line treatment for advanced muscle-invasive bladder cancer (MIBC). Therefore, the prediction of p
Autor:
Priya Pai, Guannan Wang, Wei Wen Teo, Diana Raez-Rodriguez, Kathleen L. Gabrielson, Balázs Győrffy, Bradley M. Downs, Akanksha Aggarwal, Saraswati Sukumar
Publikováno v:
Cancer Res
HOXA5 is a transcription factor and tumor suppressor that promotes differentiation of breast epithelial cells and is frequently lost during malignant transformation. HOXA5 loss alone, however, does not confer tumorigenicity. To determine which molecu
Autor:
Jette Riecks, Arianna Parnigoni, Balázs Győrffy, Ludwig Kiesel, Alberto Passi, Davide Vigetti, Martin Götte
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:3399-3419
Purpose Hyaluronan modulates tumour progression, including cell adhesion, cohesion, proliferation and invasion, and the cancer stem cell phenotype. In ovarian cancer, high levels of stromal hyaluronan are associated with poor prognosis. In this work,
Autor:
Csaba Miskey, Lacramioara Botezatu, Nuri A. Temiz, Andreas Gogol-Döring, Áron Bartha, Balázs Győrffy, David A. Largaespada, Zoltán Ivics, Attila Sebe
Publikováno v:
Molecular Cancer Research. 20:1502-1515
Metastasis, a complex, multistep process, is responsible for the overwhelming majority of cancer-related deaths. Despite its devastating consequences, it is not possible to effectively treat cancer that has spread to vital organs, the mechanisms lead
Autor:
Crismita Dmello, Aarón Sonabend, Victor A. Arrieta, Daniel Y. Zhang, Deepak Kanojia, Li Chen, Andrew Gould, Jiangshan Zhang, Seong Jae Kang, Jan Winter, Craig Horbinski, Christina Amidei, Balázs Győrffy, Alex Cordero, Catalina Lee Chang, Brandyn Castro, Patrick Hsu, Atique U. Ahmed, Maciej S. Lesniak, Roger Stupp, Adam M. Sonabend
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 14
Clin Cancer Res
Clin Cancer Res
Purpose: Paclitaxel (PTX) is one of the most potent and commonly used chemotherapies for breast and pancreatic cancer. Several ongoing clinical trials are investigating means of enhancing delivery of PTX across the blood–brain barrier for glioblast
Autor:
Pascale Palassin, Marion Lapierre, Sandrine Bonnet, Marie-Jeanne Pillaire, Balázs Győrffy, Catherine Teyssier, Stéphan Jalaguier, Jean-Sébastien Hoffmann, Vincent Cavaillès, Audrey Castet-Nicolas
Publikováno v:
Cancer Drug Resistance
Cancer Drug Resistance, 2022, 5 (2), pp.401-415. ⟨10.20517/cdr.2021.133⟩
Cancer Drug Resistance, 2022, 5 (2), pp.401-415. ⟨10.20517/cdr.2021.133⟩
International audience; Aim: The transcription factor RIP140 (receptor interacting protein of 140 kDa) is involved in intestinal tumorigenesis. It plays a role in the control of microsatellite instability (MSI), through the regulation of MSH2 and MSH
Autor:
Igor López-Cade, Vanesa García-Barberán, Esther Cabañas Morafraile, Cristina Díaz-Tejeiro, Cristina Saiz-Ladera, Adrián Sanvicente, Pedro Pérez Segura, Atanasio Pandiella, Balázs Győrffy, Alberto Ocaña
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
11 p.-6 fig.
Identification of genomic alterations that influence the immune response within the tumor microenvironment is mandatory in order to identify druggable vulnerabilities. In this article, by interrogating public genomic datasets we des
Identification of genomic alterations that influence the immune response within the tumor microenvironment is mandatory in order to identify druggable vulnerabilities. In this article, by interrogating public genomic datasets we des
Autor:
Jesus Fuentes-Antrás, Vanesa García-Barberán, Nicolas Costa-Fraga, Fernando Moreno, Aida Bao-Caamano, Aitor Rodríguez-Casanova, Alfonso López de Sá, Alicia De Luna, Igor Lopez-Cade, Carmen Ramirez-Ruda, Alejando Pascual, Pedro Perez-Segura, Balázs Győrffy, Alberto Ocaña, Angel Diaz-Lagares, Jose Angel Garcia-Saenz
Publikováno v:
Cancer Research. 82:P3-05
Background: Early-stage, node-negative, hormone receptor positive (HR+) HER2 negative (HER2-) breast cancer (BC) patients comprise a subset with good prognosis. Based on gene expression panels, these patients may skip chemotherapy and complete adjuva
Publikováno v:
Carcinogenesis
Despite advances in molecular characterization of glioblastoma multiforme (GBM), only a handful of predictive biomarkers exist with limited clinical relevance. We aimed to identify differentially expressed genes in tumor samples collected at surgery
Autor:
Martina Mazzeschi, Michela Sgarzi, Donatella Romaniello, Valerio Gelfo, Carola Cavallo, Francesca Ambrosi, Alessandra Morselli, Carmen Miano, Noemi Laprovitera, Cinzia Girone, Manuela Ferracin, Spartaco Santi, Karim Rihawi, Andrea Ardizzoni, Michelangelo Fiorentino, Gabriele D’Uva, Balázs Győrffy, Ruth Palmer, Mattia Lauriola
Publikováno v:
Journal of Experimental & Clinical Cancer Research. 41
Background In the last years, several efforts have been made to classify colorectal cancer (CRC) into well-defined molecular subgroups, representing the intrinsic inter-patient heterogeneity, known as Consensus Molecular Subtypes (CMSs). Methods In t